Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor

Y Kano, M Kato - CMAJ, 2022 - Can Med Assoc
An 86-year-old man with a 7-month history of widespread pruritic bullae was referred to our
dermatology clinic by his family physician. Physical examination showed tense bullae on his …

[CITATION][C] Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid showing positive autoantibody responses to multiple epitopes

R Kitao, T Fukumoto, T Hashimoto, K Izumi… - Journal of …, 2021 - jdsjournal.com
Bullous pemphigoid (BP) is an autoimmune blistering disease [1–4]. Although dipeptidyl
peptidase-4 inhibitors (DPP-4i) are used in diabetes mellitus patients because of relatively …

Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid diagnosed by oral manifestation

Y Yanai, Y Kori, T Fujimoto, I Imajo, R Yanai… - Journal of Oral and …, 2023 - Elsevier
There are numerous reports of bullous pemphigoid (BP) in patients taking dipeptidyl
peptidase-4 (DPP-4) inhibitors for type 2 diabetes. However, reports of this phenomenon in …

Localized bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor treatment

K Oya, M Fujii, S Taguchi, W Nishie, K Izumi… - European Journal of …, 2018 - jle.com
Figure 1. A) A single tense blister without oedematous erythema located on the right
extensor arm. B) Lymphocytes with only few eosinophils beneath the subepidermal blister …

[HTML][HTML] Successful treatment of bullous pemphigoid with baricitinib: A case report

J Ma, CP Chiang, WM Wang, CT Hung… - Dermatologica …, 2023 - journals.lww.com
A 64-year-old Taiwanese male, nonsmoker, with a history of hypertension and type 2
diabetes mellitus has been regularly taking metformin for glycemic control. The patient was …

DPP-4 inhibitor-associated bullous pemphigoid in a hemodialysis patient

J Usami, Y Takezawa - Internal Medicine, 2020 - jstage.jst.go.jp
An 85-year-old man complained of a rash on his upper limbs, chest wall and back (Picture).
He had been undergoing hemodialysis due to end-stage diabetic kidney disease and taking …

Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab.

E Sanfilippo, KM Saardi - Journal of Drugs in Dermatology: JDD, 2023 - europepmc.org
Bullous pemphigoid (BP) is an autoimmune blistering disease that typically presents with
pruritic, tense bullae in elderly patients. 1 Several recognized presentations deviate from the …

[CITATION][C] Esophageal involvement in DPP4 inhibitor‐associated bullous pemphigoid: A case report

M Brufau‐Cochs, F Alamon‐Reig… - JDDG: Journal der …, 2024 - Wiley Online Library
Dear Editors, Dipeptidyl-peptidase 4 inhibitors (DPP4i) are widely used hypoglycemic drugs
strongly associated with bullous pemphigoid (BP), the most common autoimmune …

Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors: a report of five cases

S Yoshiji, T Murakami, S Harashima… - Journal of diabetes …, 2018 - Wiley Online Library
Bullous pemphigoid (BP) is an autoimmune blistering skin disorder. Recently, BP induced
by dipeptidyl peptidase‐4 (DPP‐4) inhibitors has been a concern. Although DPP‐4 …

Pemphigoid lichen planus consequential to vildagliptin: a rare variant of bullous pemphigoid?

FJ Navarro‐Triviño, J Lopez Gomez… - International …, 2020 - search.ebscohost.com
Pemphigoid lichen planus (PLP) is currently classified as a rare variant of lichen planus (LP)
characterized by blisters located mainly on the limbs and less often in the rest of the …